Directory
>
Kiran Patel
Kiran Patel
Vice President Clinical Development, Solid Tumor Franchise | The Janssen Pharmaceutical Companies of Johnson & Johnson
United States
Kiran Patel
Summary
Kiran Patel is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President of Clinical Development for the Solid Tumor Franchise at The Janssen Pharmaceutical Companies of Johnson & Johnson. With a career spanning over two decades, Kiran has held leadership roles at several prestigious organizations, including Incyte and GlaxoSmithKline, where he has been instrumental in advancing innovative oncology treatments. His expertise encompasses clinical development, drug development, and oncology, highlighting a strong commitment to improving patient outcomes. Kiran's strategic vision and operational acumen have driven successful programs from conception through to clinical trials. He is known for fostering collaboration across multidisciplinary teams and for his ability to navigate complex regulatory environments. Kiran's contributions to the field are underscored by his extensive experience in both large pharmaceutical companies and smaller biotech firms, reflecting a versatile career trajectory. He is passionate about leveraging emerging technologies to enhance clinical practices and patient care.
Kiran Patel
Work Experience
Vice President Clinical Development, Solid Tumor Franchise at
The Janssen Pharmaceutical Companies of Johnson & Johnson
May 2015 - Present
Vice President, Clinical Development; Onco-Inflammation Program at
Incyte
May 2014 - May 2015
Vice President/Medicine Development Lead - Mekinist and Tafinlar Program at
GSK
October 2012 - April 2014
Medicine Development Lead - Mekinist and Tafinlar (Combo) Program at
GSK
January 2011 - April 2014
Physician Project Lead - Mekinist and Tafinlar (Combo) program at
GSK
June 2010 - January 2011
Medical Director at
GSK
January 2010 - June 2010
Vice President, Clinical Development and Medical Affairs at
ACT Biotech Inc
January 2008 - January 2010
Senior Medical Director - Nexavar Breast and Melanoma Program at
Onyx Pharmaceuticals, Inc., an Amgen subsidiary
January 2004 - January 2008
Frequently Asked Questions about Kiran Patel
What is Kiran Patel email address?
Kiran Patel's primary email address is ***********@janssen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kiran Patel work for?
Kiran Patel is a Vice President Clinical Development, Solid Tumor Franchise at The Janssen Pharmaceutical Companies of Johnson & Johnson, a company specializing in Pharmaceutical preparations.
How can I directly contact Kiran Patel?
To contact Kiran Patel directly, you can use the email address ***********@janssen.com. Complete contact information is available upon registration with Muraena.
Who is Kiran Patel?
Kiran Patel is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President of Clinical Development for the Solid Tumor Franchise at The Janssen Pharmaceutical Companies of Johnson & Johnson. With a career spanning over two decades, Kiran has held leadership roles at several prestigious organizations, including Incyte and GlaxoSmithKline, where he has been instrumental in advancing innovative oncology treatments. His expertise encompasses clinical development, drug development, and oncology, highlighting a strong commitment to improving patient outcomes. Kiran's strategic vision and operational acumen have driven successful programs from conception through to clinical trials. He is known for fostering collaboration across multidisciplinary teams and for his ability to navigate complex regulatory environments. Kiran's contributions to the field are underscored by his extensive experience in both large pharmaceutical companies and smaller biotech firms, reflecting a versatile career trajectory. He is passionate about leveraging emerging technologies to enhance clinical practices and patient care.
Kiran`s contact details
***********@janssen.com
Colleagues
VP of Innovation and Technology Deployment, Janssen Supply Chain
VP, Disease Area Stronghold Lead, Neurodegeneration
Venture Partner
Director IT
CIO & VP of Business Technology
Executive Sales Representative
Managing Director - the Netherlands
Vice President, Communications, The Americas
Compound Development Leader
Vice President- Global Neuroscience, Infectious Disease, Vaccines and GPH Regulatory Head